Nurix Therapeutics Inc
NASDAQ:NRIX
Nurix Therapeutics Inc
NASDAQ:NRIX
Price:
16.74
USD
4.95%
Market Closed
Market Cap:
$1.7B
Income Statement
Earnings Waterfall
Nurix Therapeutics Inc
Nurix Therapeutics Inc
Income Statement
Nurix Therapeutics Inc
Nurix Therapeutics Inc
Currency: USD
| Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Revenue |
31
N/A
|
25
-21%
|
19
-21%
|
13
-33%
|
18
+37%
|
20
+12%
|
23
+15%
|
29
+27%
|
30
+2%
|
34
+15%
|
39
+13%
|
39
+1%
|
39
-2%
|
42
+8%
|
61
+46%
|
69
+13%
|
77
+12%
|
81
+5%
|
62
-23%
|
56
-9%
|
55
-3%
|
56
+3%
|
88
+57%
|
84
-5%
|
84
+0%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(53)
|
(57)
|
(61)
|
(72)
|
(83)
|
(97)
|
(113)
|
(129)
|
(148)
|
(170)
|
(194)
|
(212)
|
(222)
|
(226)
|
(226)
|
(227)
|
(232)
|
(238)
|
(241)
|
(250)
|
(268)
|
(287)
|
(319)
|
(351)
|
(370)
|
|
| Selling, General & Administrative |
(8)
|
(9)
|
(11)
|
(13)
|
(16)
|
(20)
|
(25)
|
(29)
|
(31)
|
(34)
|
(36)
|
(37)
|
(38)
|
(39)
|
(41)
|
(41)
|
(43)
|
(45)
|
(45)
|
(46)
|
(46)
|
(46)
|
(48)
|
(50)
|
(53)
|
|
| Research & Development |
(45)
|
(48)
|
(51)
|
(59)
|
(66)
|
(77)
|
(88)
|
(100)
|
(116)
|
(137)
|
(158)
|
(175)
|
(185)
|
(187)
|
(185)
|
(186)
|
(189)
|
(193)
|
(197)
|
(204)
|
(222)
|
(241)
|
(270)
|
(301)
|
(317)
|
|
| Operating Income |
(22)
N/A
|
(32)
-43%
|
(42)
-31%
|
(59)
-40%
|
(65)
-11%
|
(77)
-18%
|
(90)
-17%
|
(100)
-11%
|
(118)
-18%
|
(136)
-15%
|
(155)
-14%
|
(173)
-11%
|
(184)
-6%
|
(184)
0%
|
(165)
+10%
|
(158)
+4%
|
(155)
+2%
|
(157)
-1%
|
(179)
-14%
|
(194)
-8%
|
(213)
-10%
|
(231)
-8%
|
(230)
+0%
|
(267)
-16%
|
(286)
-7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
6
|
8
|
10
|
11
|
13
|
14
|
17
|
20
|
22
|
24
|
23
|
22
|
|
| Pre-Tax Income |
(21)
N/A
|
(31)
-45%
|
(41)
-32%
|
(57)
-39%
|
(64)
-11%
|
(76)
-19%
|
(89)
-18%
|
(99)
-12%
|
(117)
-18%
|
(135)
-16%
|
(155)
-14%
|
(171)
-11%
|
(180)
-5%
|
(179)
+1%
|
(157)
+12%
|
(149)
+6%
|
(144)
+3%
|
(145)
0%
|
(165)
-14%
|
(177)
-7%
|
(193)
-9%
|
(208)
-8%
|
(206)
+1%
|
(244)
-18%
|
(264)
-8%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
20
|
20
|
21
|
20
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
(22)
|
(31)
|
(21)
|
(37)
|
(43)
|
(55)
|
(89)
|
(99)
|
(117)
|
(135)
|
(154)
|
(171)
|
(180)
|
(179)
|
(157)
|
(149)
|
(144)
|
(145)
|
(165)
|
(177)
|
(194)
|
(208)
|
(207)
|
(245)
|
(264)
|
|
| Net Income (Common) |
(22)
N/A
|
(31)
-45%
|
(21)
+34%
|
(37)
-78%
|
(43)
-17%
|
(55)
-27%
|
(89)
-62%
|
(99)
-12%
|
(117)
-18%
|
(135)
-16%
|
(154)
-14%
|
(171)
-11%
|
(180)
-5%
|
(179)
+1%
|
(157)
+12%
|
(149)
+6%
|
(144)
+3%
|
(145)
-1%
|
(165)
-14%
|
(177)
-7%
|
(194)
-9%
|
(208)
-8%
|
(207)
+1%
|
(245)
-18%
|
(264)
-8%
|
|
| EPS (Diluted) |
-1.91
N/A
|
-2.76
-45%
|
-1.82
+34%
|
-1.17
+36%
|
-1.11
+5%
|
-1.42
-28%
|
-2.03
-43%
|
-2.24
-10%
|
-2.73
-22%
|
-3.05
-12%
|
-3.46
-13%
|
-3.36
+3%
|
-3.71
-10%
|
-3.3
+11%
|
-2.9
+12%
|
-2.75
+5%
|
-2.65
+4%
|
-2.65
N/A
|
-2.64
+0%
|
-2.43
+8%
|
-2.88
-19%
|
-2.49
+14%
|
-2.47
+1%
|
-2.9
-17%
|
-3.05
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
